Wiltbank T B, McCarroll D R, Wartick M G
Department of Pathology, University of Illinois College of Medicine, Peoria.
Transfusion. 1989 Jan;29(1):75-7. doi: 10.1046/j.1537-2995.1989.29189101170.x.
Since the institution of routine testing for antibodies to Human Immunodeficiency Virus (HIV) using the enzyme-linked immunosorbent assay (ELISA), the specificity and sensitivity of this assay system has received significant scrutiny. During previous use of this methodology, we have quantified rates of false biological positive results using commercial kit assays in a normal donor population. In this study, we have identified a potential source for false negative results. Using multiple lots of two different commercial ELISA kits, the absorbance readings at the test end point could not differentiate between normal non-reactive donor samples and blanks containing no sample. These results occur using normal donor samples, even though the assays could distinguish between blank wells and the manufacturers' "normal controls", provided with the assay. Our findings suggest that a technical pipetting error is presently undetectable, either visually or by statistical methods, and could permit an untested, potentially HIV-1 positive, unit to be released into the transfusable blood supply. A possible solution is suggested.
自从采用酶联免疫吸附测定法(ELISA)对人类免疫缺陷病毒(HIV)抗体进行常规检测以来,该检测系统的特异性和敏感性受到了广泛审查。在之前使用这种方法的过程中,我们在正常献血者群体中使用商业试剂盒测定法对假生物学阳性结果的发生率进行了量化。在本研究中,我们发现了假阴性结果的一个潜在来源。使用两种不同商业ELISA试剂盒的多个批次,测试终点的吸光度读数无法区分正常无反应的献血者样本和不含样本的空白对照。即使这些检测能够区分空白孔和试剂盒提供的制造商“正常对照”,使用正常献血者样本时仍会出现这些结果。我们的研究结果表明,目前无论是通过视觉还是统计方法都无法检测到技术移液误差,这可能会使一份未经检测、潜在HIV-1阳性的血液成分被放行进入可用于输血的血液供应中。文中提出了一个可能的解决方案。